pmc logo image
Logo of brmedjBMJ helping doctors make better decisionsSearchLatest content

Formats:

Br Med J. 1976 April 24; 1(6016): 990–991.
PMCID: PMC1639643
Once-daily dosing with Atenolol in patients with mild or moderate hypertension.
A P Douglas-Jones and J M Cruickshank
Abstract
Because of the difficulties patients have in adhering to their drug regimens a trial was performed in which patients with essential hypertension were given, in random order and for four weeks each, three different doses of atenolol to be taken once daily. Atenolol effectively decreased lying and standing blood pressures, and there was no difference between the effects of the three doses. The simplicity of the regimen, as well as atenolol's freedom from troublesome side effects, should be valuable in helping patients adhere to long-term treatment.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (416K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Hansson L, Aberg H, Jameson S, Karlberg B, Malmcrona R. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. Acta Med Scand. 1973 Dec;194(6):549–550. [PubMed]
  • Petrie JC, Galloway DB, Webster J, Simpson WT, Lewis JA. Atenolol and bendrofluazide in hypertension. Br Med J. 1975 Oct 18;4(5989):133–135. [PubMed]
  • Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973 Aug 2;289(5):249–252. [PubMed]
  • Marlin GE, Kumana CR, Kaye CM, Smith DM, Turner P. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol. 1975 Apr;2(2):151–157. [PubMed]